BioArctic
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
BIOA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010323303 (+1 more)
- LEI:
- 549300Y0OI2WVUNHLC33
- Country:
- Sweden
- Address:
- Warfvinges väg 35, 112 51 Stockholm
- Website:
- https://www.bioarctic.se/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BioArctic is a Swedish research-intensive biopharmaceutical company focused on developing novel, disease-modifying treatments and diagnostics for neurodegenerative disorders. The company's core mission is to address the underlying causes of diseases such as Alzheimer's and Parkinson's. Its research is centered on developing innovative drugs and antibodies that target the root mechanisms of nerve cell damage and misfolded proteins, aiming to provide effective solutions for significant unmet medical needs within the central nervous system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-13 08:00 |
BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive…
|
English | 188.3 KB | ||
| 2025-06-13 08:00 |
BioArctic initierar nästa steg i fas 2a-studien av exidavnemab efter positiv sä…
|
Swedish | 223.8 KB | ||
| 2025-05-30 18:30 |
Number of shares and votes in BioArctic AB (publ) as of May 30, 2025
|
English | 163.0 KB | ||
| 2025-05-30 18:30 |
Antal aktier och röster i BioArctic AB (publ) per den 30 maj 2025
|
Swedish | 159.1 KB | ||
| 2025-05-22 18:19 |
Kommuniké från årsstämma i BioArctic AB (publ)
|
Swedish | 194.1 KB | ||
| 2025-05-22 18:19 |
Bulletin from the Annual General Meeting in BioArctic AB (publ)
|
English | 192.8 KB | ||
| 2025-05-22 15:15 |
BioArctic receives positive opinion for Orphan Medicinal Product Designation in…
|
English | 172.1 KB | ||
| 2025-05-22 15:15 |
BioArctic erhåller positiv rekommendation för särläkemedelsklassificering i EU …
|
Swedish | 190.7 KB | ||
| 2025-05-21 08:00 | Swedish | 14.5 MB | |||
| 2025-05-21 08:00 | English | 14.5 MB | |||
| 2025-05-15 06:00 |
Eisai prognosticerar 76,5 miljarder JPY i försäljning av Leqembi® för bolagets …
|
Swedish | 247.5 KB | ||
| 2025-05-15 06:00 |
Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 …
|
English | 266.6 KB | ||
| 2025-05-01 12:45 |
Sales of Leqembi[®] totaled 14.7 billion yen in the first quarter 2025
|
English | 187.6 KB | ||
| 2025-05-01 12:45 |
Försäljningen av Leqembi[®] uppgick till 14,7 miljarder yen under det första kv…
|
Swedish | 190.4 KB | ||
| 2025-04-22 20:00 |
Notice of Annual General Meeting 2025 in BioArctic AB (publ)
|
English | 269.5 KB |
Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioArctic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioArctic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-13 | Gunilla Osswald | Other | Sell | 40,000 | 8,821,200.00 SEK |
| 2025-02-13 | Gunilla Osswald | Other | Other | 40,000 | 3,344,000.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Sell | 6,000 | 1,323,180.00 SEK |
| 2025-02-13 | Sten Mikael Moge | Other | Other | 6,000 | 501,600.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Sell | 1,500 | 330,795.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 2,500 | 209,000.00 SEK |
| 2025-02-13 | Johanna Margareta Fälting | Other | Other | 1,500 | 125,400.00 SEK |
| 2025-01-10 | Mikael Smedeby | Other | Buy | 730 | 148,920.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 2,000 | 446,000.00 SEK |
| 2024-12-19 | Oskar Bosson | Other | Sell | 871 | 195,626.60 SEK |
Peer Companies
